280 related articles for article (PubMed ID: 7863328)
41. Transcriptional repression by the orphan steroid receptor RVR/Rev-erb beta is dependent on the signature motif and helix 5 in the E region: functional evidence for a biological role of RVR in myogenesis.
Burke L; Downes M; Carozzi A; Giguère V; Muscat GE
Nucleic Acids Res; 1996 Sep; 24(18):3481-9. PubMed ID: 8836172
[TBL] [Abstract][Full Text] [Related]
42. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.
Wu H; Wade M; Krall L; Grisham J; Xiong Y; Van Dyke T
Genes Dev; 1996 Feb; 10(3):245-60. PubMed ID: 8595876
[TBL] [Abstract][Full Text] [Related]
43. Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways.
Lawlor MA; Rotwein P
J Cell Biol; 2000 Dec; 151(6):1131-40. PubMed ID: 11121430
[TBL] [Abstract][Full Text] [Related]
44. MyoD induces the expression of p57Kip2 in cells lacking p21Cip1/Waf1: overlapping and distinct functions of the two cdk inhibitors.
Figliola R; Maione R
J Cell Physiol; 2004 Sep; 200(3):468-75. PubMed ID: 15254975
[TBL] [Abstract][Full Text] [Related]
45. Rb functions to inhibit apoptosis during myocyte differentiation.
Wang J; Guo K; Wills KN; Walsh K
Cancer Res; 1997 Feb; 57(3):351-4. PubMed ID: 9012453
[TBL] [Abstract][Full Text] [Related]
46. Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.
Tintignac LA; Sirri V; Leibovitch MP; Lécluse Y; Castedo M; Metivier D; Kroemer G; Leibovitch SA
Mol Cell Biol; 2004 Feb; 24(4):1809-21. PubMed ID: 14749395
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of cell cycle inhibitors (p16INK4 and p21Cip1) and cyclin D1 using adenovirus vectors regulates proliferation of rat mesangial cells.
Terada Y; Yamada T; Nakashima O; Tamamori M; Ito H; Sasaki S; Marumo F
J Am Soc Nephrol; 1997 Jan; 8(1):51-60. PubMed ID: 9013448
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
49. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
Nakanishi M; Kagawa Y; Takahashi H; Matsushime H
Leukemia; 1997 Apr; 11 Suppl 3():356-7. PubMed ID: 9209388
[TBL] [Abstract][Full Text] [Related]
50. Stabilization of MyoD by direct binding to p57(Kip2).
Reynaud EG; Leibovitch MP; Tintignac LA; Pelpel K; Guillier M; Leibovitch SA
J Biol Chem; 2000 Jun; 275(25):18767-76. PubMed ID: 10764802
[TBL] [Abstract][Full Text] [Related]
51. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).
Perez-Roger I; Kim SH; Griffiths B; Sewing A; Land H
EMBO J; 1999 Oct; 18(19):5310-20. PubMed ID: 10508164
[TBL] [Abstract][Full Text] [Related]
52. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.
Franklin DS; Xiong Y
Mol Biol Cell; 1996 Oct; 7(10):1587-99. PubMed ID: 8898364
[TBL] [Abstract][Full Text] [Related]
53. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.
Parker SB; Eichele G; Zhang P; Rawls A; Sands AT; Bradley A; Olson EN; Harper JW; Elledge SJ
Science; 1995 Feb; 267(5200):1024-7. PubMed ID: 7863329
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
Wang J; Walsh K
Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
[TBL] [Abstract][Full Text] [Related]
55. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
Hunter T; Pines J
Cell; 1994 Nov; 79(4):573-82. PubMed ID: 7954824
[No Abstract] [Full Text] [Related]
56. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
Lukas J; Parry D; Aagaard L; Mann DJ; Bartkova J; Strauss M; Peters G; Bartek J
Nature; 1995 Jun; 375(6531):503-6. PubMed ID: 7777060
[TBL] [Abstract][Full Text] [Related]
57. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells.
Kaliman P; Viñals F; Testar X; Palacín M; Zorzano A
J Biol Chem; 1996 Aug; 271(32):19146-51. PubMed ID: 8702591
[TBL] [Abstract][Full Text] [Related]
58. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
Sweeney KJ; Swarbrick A; Sutherland RL; Musgrove EA
Oncogene; 1998 Jun; 16(22):2865-78. PubMed ID: 9671407
[TBL] [Abstract][Full Text] [Related]
59. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1.
Dierov J; Prosniak M; Gallia G; Gartenhaus RB
J Cell Biochem; 1999 Sep; 74(4):544-50. PubMed ID: 10440924
[TBL] [Abstract][Full Text] [Related]
60. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
Matsuoka M; Tani K; Asano S
Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
